Drugs / NZV930
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04237649 | Feb 2020 → Sep 2023 | cancer | Novartis Pharmaceuticals | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NZV930 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04237649 ↗ |
| Known as | SRF-373 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594582 ↗ |